The FDA has approved the immunotherapy daratumumab (Darzalex, Janssen) in combination with pomalidomide (Pomalyst, Celgene) and dexamethasone for the treatment of patients with multiple myeloma who have received at least two prior therapies, including lenalidomide (Revlimid, Celgene) (an immunomodulatory agent) and a proteasome inhibitor (PI).

The FDA has expanded the approved uses of Dysport (abobotulinumtoxinA, Ipsen Biopharmaceuticals) for the treatment of lower-limb spasticity in adults. Dysport is an injectable form of botulinum toxin type A (BoNT-A), which is isolated and purified from Clostridium bacteria producing BoNT-A. It is supplied as a lyophilized powder.

The insurance industry is keeping its cards close to its chest in the debate over Republican efforts to overhaul the ACA, the Wall Street Journal reports. Industry leaders are making their thoughts heard quietly.

The federal government says that hospitals and other organizations that process or store patient health care information must report cyber breaches to HHS. But the rules are murky, and some of the worst cyberattacks have not been brought to light, the Wall Street Journal reports.

The Cleveland Clinic and Oscar Health have made arrangements to offer co-branded health insurance plans to consumers in Ohio, marking the Clinic’s first entry into the health insurance market with a product bearing its name, according to an announcement posted on the PR Newswire website.

According to a new survey from Premier, Inc., a health-care improvement company, drug spending has increased among health care leaders––a trend that is expected to continue during the next five years. To counteract this drain on hospital budgets, health-system leaders are employing various methods and strategies to ease the burden.

The FDA has approved Symjepi (epinephrine injection, USP, 1:1,000 [0.3 mg], Adamis Pharmaceuticals) for the emergency treatment of allergic reactions (type I), including anaphylaxis.

Scientists at Rutgers University–New Brunswick and the biotechnology company Naicons have discovered a new antibiotic that is effective against drug-resistant bacteria: pseudouridimycin. The new antibiotic is produced by a microbe found in a soil sample collected in Italy.

A group of state attorneys general have announced that they are jointly investigating the marketing and sales practices of drug companies that manufacture opioid painkillers, according to a Reuters report.

For nearly two decades, researchers have sought a way to target an estrogen receptor in the hope that they could improve breast cancer survival, but an article published in Nature Communications contends that the effort may never pan out. The reason? The target receptor doesn’t appear to be where scientists thought it was.

While the era of double-digit growth in health care costs seems to have ended, the “new normal” pace of around 6% to 7% per year is still unsustainable, according to an article posted on the Modern Healthcare website. The report quotes from a new study by PricewaterhouseCoopers’ Health Research Institute (HRI).

The final updated ICD-10-CM codes for 2018, posted on the Centers for Medicare and Medicaid Services’ (CMS) website, contain 360 new, 142 deleted, and 226 revised diagnosis codes, according to a report from HealthLeaders Media.

As prescription drug prices have spiked—often without reason—the American Medical Association (AMA) has advocated for more transparency in pricing to protect patients.

New research has suggested a link between the trillions of bacteria that inhabit the human bowels and the efficacy of immune therapies.

The Trump administration is drafting an executive order to rein in prescription drug prices, according to an article posted on the BioCentury website.

Pages